You only need to hold a small amount to be qualified to buy more shares through the offering, so it's possible the insiders intend to buy a lot more.
Biotech market is so hard IMO. Some companies get a great valuation for their product (SVRA, in my opinion), then they either rise or collapse on news, while others get great news yet never seem to get any value for their assets.
Anyway, I wish I kept focused on commodity stocks. I seemed better able to predict the price movements/valuations of those.